Vera Therapeutics (VERA) Short Interest Ratio & Short Volume $23.46 +0.27 (+1.14%) As of 01:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vera Therapeutics Short Interest DataVera Therapeutics (VERA) has a short interest of 159,700 shares, representing 0.23% of the float (the number of shares available for trading by the public). This marks a -98.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 995,155 shares to cover all short positions.Current Short Interest159,700 sharesPrevious Short Interest9,560,000 sharesChange Vs. Previous Month-98.33%Dollar Volume Sold Short$3.76 millionShort Interest Ratio0.7 Days to CoverLast Record DateJune 30, 2025Outstanding Shares63,770,000 sharesFloat Size70,100,000 sharesShort Percent of Float0.23%Today's Trading Volume346,631 sharesAverage Trading Volume995,155 sharesToday's Volume Vs. Average35% Short Selling Vera Therapeutics? Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVERA Short Interest Over TimeVERA Days to Cover Over TimeVERA Percentage of Float Shorted Over Time Vera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025159,700 shares $3.76 million -98.3%0.2%0.7 $23.56 6/15/20259,560,000 shares $217.39 million +6.8%20.8%5.5 $22.74 5/31/20258,950,000 shares $170.23 million +26.6%18.6%5.7 $19.02 5/15/20257,070,000 shares $150.80 million +18.6%14.7%7.1 $21.33 4/30/20255,960,000 shares $139.29 million -2.0%12.2%5.4 $23.37 4/15/20256,080,000 shares $131.27 million -7.0%12.4%6.4 $21.59 3/31/20256,540,000 shares $157.09 million -9.8%13.4%7 $24.02 3/15/20257,250,000 shares $202.93 million -7.1%14.8%8.6 $27.99 2/28/20257,800,000 shares $233.45 million -6.7%15.9%9.8 $29.93 2/15/20258,360,000 shares $229.57 million +3.2%17.2%11 $27.46 Get the Latest News and Ratings for VERA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20258,100,000 shares $301.97 million +11.1%16.6%12.2 $37.28 1/15/20257,290,000 shares $246.99 million +2.0%14.9%9.2 $33.88 12/31/20247,150,000 shares $302.37 million +5.2%14.6%9.8 $42.29 12/15/20246,800,000 shares $299.54 million +4.3%13.9%9.3 $44.05 11/30/20246,520,000 shares $324.37 million -0.5%13.3%8.6 $49.75 11/15/20246,550,000 shares $303.00 million +2.5%14.0%8.7 $46.26 10/31/20246,390,000 shares $258.03 million +3.2%13.3%9 $40.38 10/15/20246,190,000 shares $248.90 million +0.3%14.9%11.7 $40.21 9/30/20246,170,000 shares $272.71 million -4.5%14.9%11.3 $44.20 9/15/20246,460,000 shares $242.31 million +6.8%15.6%11.6 $37.51 8/31/20246,050,000 shares $228.81 million -0.5%14.6%11.3 $37.82 8/15/20246,080,000 shares $226.42 million -0.2%14.7%9.9 $37.24 7/31/20246,090,000 shares $222.83 million +1.7%14.7%9.4 $36.59 7/15/20245,990,000 shares $220.13 million -2.1%14.4%8.2 $36.75 6/30/20246,120,000 shares $221.42 million -0.1%14.7%6.9 $36.18 6/15/20246,123,800 shares $220.58 million +0.9%14.7%6.7 $36.02 5/31/20246,070,000 shares $230.60 million -6.0%14.5%6.6 $37.99 5/15/20246,460,000 shares $275.78 million -5.0%15.5%6.7 $42.69 4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51 4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53 3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12 3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25 2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08 2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51 1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42 1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95 12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38 12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00 11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55 11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36Banks aren’t ready for this altcoin—are you? (Ad)Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…Discover our #1 crypto for the market right now. 10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42 10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64 9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71 9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09 8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69 8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69 7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77 7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94 6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05 6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72 5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35 5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97 4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65 4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27 3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76 3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13 2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43 2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87 1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48 1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74 12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35 12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17 11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70 11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85 10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64 10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18 9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31 9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37 8/31/20221,570,000 shares $34.12 million +4.0%13.2%18 $21.73 8/15/20221,510,000 shares $32.69 million +14.4%12.6%18.9 $21.65 7/31/20221,320,000 shares $22.77 million +16.8%11.1%15 $17.25 7/15/20221,130,000 shares $18.14 million +20.1%9.5%12 $16.05 6/30/2022941,300 shares $12.81 million +28.2%7.9%10.2 $13.61 6/15/2022734,500 shares $10.28 million +83.6%6.2%8.2 $13.99 5/31/2022400,000 shares $5.82 million -12.5%3.3%4.1 $14.54 5/15/2022456,900 shares $6.99 million +8.1%3.8%4.7 $15.29 4/30/2022422,600 shares $8.45 million +41.2%3.4%3.6 $20.00 4/15/2022299,200 shares $6.92 million -46.3%2.4%2.7 $23.12 3/31/2022557,000 shares $13.08 million +40.1%4.5%5.3 $23.49 3/15/2022397,700 shares $9.55 million +39.1%3.1%3.6 $24.01 2/28/2022286,000 shares $6.64 million -16.7%2.2%2.8 $23.21 2/15/2022343,400 shares $6.81 million -4.3%3.7%3.5 $19.83 1/31/2022358,800 shares $7.15 million +27.9%4.9%5.2 $19.93 1/15/2022280,600 shares $5.61 million +15.6%3.8%4.6 $19.99 12/31/2021242,700 shares $6.48 million +185.2%3.3%4.2 $26.72 12/15/202185,100 shares $1.92 million +7.2%1.2%1.4 $22.51 11/30/202179,400 shares $2.84 million -36.6%1.1%1 $35.80 11/15/2021125,200 shares $2.93 million -32.4%1.7%1.6 $23.40 10/29/2021185,100 shares $3.58 million +43.8%2.5%2.6 $19.35 10/15/2021128,700 shares $1.93 million +15.8%1.7%1.8 $15.01Banks aren’t ready for this altcoin—are you? (Ad)Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…Discover our #1 crypto for the market right now. 9/30/2021111,100 shares $1.93 million +376.8%1.5%1.7 $17.35 9/15/202123,300 shares $712.98 thousand +651.6%0.3%0.4 $30.60 8/31/20213,100 shares $45.69 thousand +24.0%0.0%0.1 $14.74 8/13/20212,500 shares $42.35 thousand No Change0.0%0.1 $16.94 VERA Short Interest - Frequently Asked Questions What is Vera Therapeutics' current short interest? Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 159,700 shares of VERA short. 0.23% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest. What is a good short interest ratio for Vera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 1.0. Learn More on Vera Therapeutics's short interest ratio. Which institutional investors are shorting Vera Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vera Therapeutics: Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.23% of Vera Therapeutics' floating shares are currently sold short. Is Vera Therapeutics' short interest increasing or decreasing? Vera Therapeutics saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 159,700 shares, a drop of 98.3% from the previous total of 9,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vera Therapeutics' float size? Vera Therapeutics currently has issued a total of 63,770,000 shares. Some of Vera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vera Therapeutics currently has a public float of 70,100,000 shares. How does Vera Therapeutics' short interest compare to its competitors? 0.23% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vera Therapeutics: TG Therapeutics, Inc. (16.96%), Nuvalent, Inc. (12.49%), Lantheus Holdings, Inc. (12.95%), Axsome Therapeutics, Inc. (10.66%), CRISPR Therapeutics AG (30.90%), ADMA Biologics Inc (7.05%), Rhythm Pharmaceuticals, Inc. (8.12%), Vaxcyte, Inc. (11.26%), Akero Therapeutics, Inc. (12.23%), Krystal Biotech, Inc. (12.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Vera Therapeutics stock? Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading down $0.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vera Therapeutics? A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further. How often is Vera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies TGTX Short Interest NUVL Short Interest LNTH Short Interest AXSM Short Interest CRSP Short Interest ADMA Short Interest RYTM Short Interest PCVX Short Interest AKRO Short Interest KRYS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VERA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
